메뉴 건너뛰기




Volumn 78, Issue 11, 2010, Pages 612-616

Care of insulin resistance in polycystic ovary syndrome;Atención de la resistencia a la insulina en el síndrome de ovarios poliquísticos

Author keywords

Insulin resistance; Insulin sensitizers; Polycystic ovary syndrome

Indexed keywords

AMINO ACID; FREE RADICAL; INSULIN; INSULIN SENSITIZING AGENT; METFORMIN; PIOGLITAZONE;

EID: 78649365292     PISSN: 03009041     EISSN: 03009041     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (11)

References (30)
  • 1
    • 0029095150 scopus 로고
    • Polycystic ovary syndrome
    • Franks S. Polycystic ovary syndrome. N Engl J Med 1995;333:853-861.
    • (1995) N Engl J Med , vol.333 , pp. 853-861
    • Franks, S.1
  • 2
    • 75149149933 scopus 로고    scopus 로고
    • Prevalence of polycystic ovary syndrome and related disorders in mexican women
    • Moran C, Tena G, Moran S, Ruiz P, Reyna R, Duque X. Prevalence of polycystic ovary syndrome and related disorders in mexican women. Gynecol Obstet Invest 2010;69:274-280.
    • (2010) Gynecol Obstet Invest , vol.69 , pp. 274-280
    • Moran, C.1    Tena, G.2    Moran, S.3    Ruiz, P.4    Reyna, R.5    Duque, X.6
  • 3
    • 77956399354 scopus 로고    scopus 로고
    • Polycystic ovaries and associated clinical and biochemical features among women with infertility in a tertiary hospital in Tanzania
    • Pembe AB, Abeid MS. Polycystic ovaries and associated clinical and biochemical features among women with infertility in a tertiary hospital in Tanzania. Tanzan J Health Res 2009;11:175-180.
    • (2009) Tanzan J Health Res , vol.11 , pp. 175-180
    • Pembe, A.B.1    Abeid, M.S.2
  • 4
    • 78649366433 scopus 로고    scopus 로고
    • Síndrome de ovarios poliquísticos: Una entidad sistémica metabólica
    • Zárate A, Hernández-Valencia M. Síndrome de ovarios poliquísticos: una entidad sistémica metabólica. Rev Med UNAM 1997;40:230-233.
    • (1997) Rev Med UNAM , vol.40 , pp. 230-233
    • Zárate, A.1    Hernández-Valencia, M.2
  • 5
    • 0346186090 scopus 로고    scopus 로고
    • Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome (PCOS). The Rotterdam ESHRE/ASRM sponsored PCOS consensus workshop group
    • Fauser BCJM. Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome (PCOS). The Rotterdam ESHRE/ASRM sponsored PCOS consensus workshop group. Hum Reprod 2004;19:41-47.
    • (2004) Hum Reprod , vol.19 , pp. 41-47
    • Fauser, B.C.J.M.1
  • 6
    • 33644829109 scopus 로고    scopus 로고
    • Diagnosis of polycystic ovarian syndrome: In defense of the Rotterdam criteria
    • DOI 10.1210/jc.2005-2501
    • Franks S. Diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria. J Clin Endocrinol Metab 2006;91:786-789. (Pubitemid 43357737)
    • (2006) Journal of Clinical Endocrinology and Metabolism , vol.91 , Issue.3 , pp. 786-789
    • Franks, S.1
  • 7
    • 33644818900 scopus 로고    scopus 로고
    • Diagnosis of polycystic ovarian syndrome: The Rotterdam criteria are premature
    • DOI 10.1210/jc.2005-2153
    • Azziz R. Diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. J Clin Endocrinol Metab 2006;91:781-785. (Pubitemid 43357736)
    • (2006) Journal of Clinical Endocrinology and Metabolism , vol.91 , Issue.3 , pp. 781-785
    • Azziz, R.1
  • 8
    • 59349098805 scopus 로고    scopus 로고
    • The androgen excess and PCOS Society criteria for the polycystic ovary syndrome: The complete task force report
    • Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis EA, et al. The androgen excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 2009;91:456-488.
    • (2009) Fertil Steril , vol.91 , pp. 456-488
    • Azziz, R.1    Carmina, E.2    Dewailly, D.3    Diamanti-Kandarakis, E.A.4
  • 9
    • 0031456016 scopus 로고    scopus 로고
    • Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis
    • DOI 10.1210/er.18.6.774
    • Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanisms and implications for pathogenesis. Endocr Rev 1997;18:774-800. (Pubitemid 28009567)
    • (1997) Endocrine Reviews , vol.18 , Issue.6 , pp. 774-800
    • Dunaif, A.1
  • 10
    • 78649363612 scopus 로고    scopus 로고
    • Conceptos actuales en hiperandrogenismo, síndrome de ovario poliquístico y resistencia a la insulina
    • Morán C. Conceptos actuales en hiperandrogenismo, síndrome de ovario poliquístico y resistencia a la insulina. Rev Endo Nut 2006;14:25-32.
    • (2006) Rev Endo Nut , vol.14 , pp. 25-32
    • Morán, C.1
  • 11
    • 78649354651 scopus 로고    scopus 로고
    • Participación del factor de crecimiento insulinoide (IGF) en el síndrome de ovario poliquístico (síndrome de ovarios poliquísticos)
    • Aquino P, Hernández-Valencia M, Hicks J, Fonseca M. Participación del factor de crecimiento insulinoide (IGF) en el síndrome de ovario poliquístico (síndrome de ovarios poliquísticos). Ginecol Obstet Mex 1999;66:267-271.
    • (1999) Ginecol Obstet Mex , vol.66 , pp. 267-271
    • Aquino, P.1    Hernández-Valencia, M.2    Hicks, J.3    Fonseca, M.4
  • 12
    • 0029796476 scopus 로고    scopus 로고
    • Decreases in ovarian cytochrome P450c 17 activity and serum free testosterone after reduction in insulin secretion in women with polycystic ovary syndrome
    • Nestler JE, Jakubowicz DJ. Decreases in ovarian cytochrome P450c 17 activity and serum free testosterone after reduction in insulin secretion in women with polycystic ovary syndrome. N Engl J Med 1996;335:617-623.
    • (1996) N Engl J Med , vol.335 , pp. 617-623
    • Nestler, J.E.1    Jakubowicz, D.J.2
  • 14
    • 20444501776 scopus 로고    scopus 로고
    • Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS)
    • Kumar A, Woods KS, Bartolucci AA, Azziz R. Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS). Clinical Endocrinology 2005;62:1-6.
    • (2005) Clinical Endocrinology , vol.62 , pp. 1-6
    • Kumar, A.1    Woods, K.S.2    Bartolucci, A.A.3    Azziz, R.4
  • 15
    • 33749179678 scopus 로고    scopus 로고
    • Repercusión en las alteraciones en los mecanismos de señalización del receptor de insulina
    • Hernández-Valencia M. Repercusión en las alteraciones en los mecanismos de señalización del receptor de insulina. Rev Med Inst Mex Seguro Soc 2006;44:383-388.
    • (2006) Rev Med Inst Mex Seguro Soc , vol.44 , pp. 383-388
    • Hernández-Valencia, M.1
  • 17
    • 0026620885 scopus 로고
    • Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?
    • Carmina E, Koyama T, Chang L, Stanczyk FZ, Lobo RA. Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am J Obstet Gynecol 1992;167:1807-1812.
    • (1992) Am J Obstet Gynecol , vol.167 , pp. 1807-1812
    • Carmina, E.1    Koyama, T.2    Chang, L.3    Stanczyk, F.Z.4    Lobo, R.A.5
  • 18
    • 0942265414 scopus 로고    scopus 로고
    • Detecting Insulin Resistance in Polycystic Ovary Syndrome: Purposes and Pitfalls
    • DOI 10.1097/01.OGX.0000109523.25076.E2
    • Legro RS, Castracane VD, Kauffman RP. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv 2004;59:141-154. (Pubitemid 38140845)
    • (2004) Obstetrical and Gynecological Survey , vol.59 , Issue.2 , pp. 141-154
    • Legro, R.S.1    Castracane, V.D.2    Kauffman, R.P.3
  • 20
    • 0032421859 scopus 로고    scopus 로고
    • Polycystic ovary syndrome: Metabolic challenges and new treatment options
    • Bachmann GA. Polycystic ovary syndrome: metabolic challenges and new treatment options. Am J Obstet Gynecol 1998;179:87-88.
    • (1998) Am J Obstet Gynecol , vol.179 , pp. 87-88
    • Bachmann, G.A.1
  • 22
    • 0028315971 scopus 로고
    • Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy
    • DOI 10.1016/0026-0495(94)90209-7
    • Velazquez EM, Mendoza S, Hamer T, Sosa F, Glueck CJ. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, by hyperandrogenemia, and systolic blood pressure faciliting normal menses and pregnancy. Metabolism 1994;43:647-654. (Pubitemid 24145474)
    • (1994) Metabolism: Clinical and Experimental , vol.43 , Issue.5 , pp. 647-654
    • Velazquez, E.M.1    Mendoza, S.2    Hamer, T.3    Sosa, F.4    Glueck, C.J.5
  • 24
    • 0031308226 scopus 로고    scopus 로고
    • Empleo de metformina en el manejo de adolescentes con el síndrome de ovarios poliquísticos
    • Zárate A, Hernández-Valencia M, Fonseca M, Ochoa R. Empleo de metformina en el manejo de adolescentes con el síndrome de ovarios poliquísticos. Ginecol Obstet Mex 1997;65:504-508.
    • (1997) Ginecol Obstet Mex , vol.65 , pp. 504-508
    • Zárate, A.1    Hernández-Valencia, M.2    Fonseca, M.3    Ochoa, R.4
  • 25
    • 78649350787 scopus 로고    scopus 로고
    • Polycystic ovary syndrome: It's not just infertility
    • Hunter MH, Sterret JJ. Polycystic ovary syndrome: it's not just infertility. Am Family Phys 2000;12:456-459.
    • (2000) Am Family Phys , vol.12 , pp. 456-459
    • Hunter, M.H.1    Sterret, J.J.2
  • 26
    • 57349135982 scopus 로고    scopus 로고
    • Impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women: Do we need a new drug?
    • Legro RS. Impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women: do we need a new drug? J Clin Endocrinol Metab 2008;93:4218-4220.
    • (2008) J Clin Endocrinol Metab , vol.93 , pp. 4218-4220
    • Legro, R.S.1
  • 27
    • 78649385814 scopus 로고    scopus 로고
    • Utility of Diamel in patients with type 2 diabetes mellitus receiving combination therapy with glibenclamide
    • Hernandez YJA, Vargas GD. Utility of Diamel in patients with type 2 diabetes mellitus receiving combination therapy with glibenclamide. Av Diabetol 2006;23:284-290.
    • (2006) Av Diabetol , vol.23 , pp. 284-290
    • Hernandez, Y.J.A.1    Vargas, G.D.2
  • 28
    • 0031967640 scopus 로고    scopus 로고
    • Tissue ascorbic acid and polyol pathway metabolism in experimental diabetes
    • Lindsay RM
    • Tissue ascorbic acid and polyol pathway metabolism in experimental diabetes. Lindsay RM. Diabetologia 1998;41:516-523.
    • (1998) Diabetologia , vol.41 , pp. 516-523
  • 30
    • 0030047163 scopus 로고    scopus 로고
    • Polycystic ovary syndrome -from gynecological curiosity to multisystem endocrinopathology
    • Hamburg R. Polycystic ovary syndrome -from gynecological curiosity to multisystem endocrinopathology. Hum Reprod 1996;10:29-39.
    • (1996) Hum Reprod , vol.10 , pp. 29-39
    • Hamburg, R.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.